• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UVaDOCCommunitiesBy Issue DateAuthorsSubjectsTitles

    My Account

    Login

    Statistics

    View Usage Statistics

    Share

    View Item 
    •   UVaDOC Home
    • SCIENTIFIC PRODUCTION
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • View Item
    •   UVaDOC Home
    • SCIENTIFIC PRODUCTION
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • View Item
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Export

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/5836

    Título
    Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels
    Autor
    González Castañeda, Candelas
    Pérez Castrillon, José LuisAutoridad UVA
    Romero Gómez, Mercedes
    Herreros Fernández, Vicente
    Año del Documento
    2002
    Editorial
    Elsevier Science Ireland Ltd.
    Descripción
    Producción Científica
    Documento Fuente
    International Journal of Cardiology, 2002, vol. 82, p. 293-295
    Abstract
    Chlamydia pneumoniae infection has long been suspected as a possible cause of atherosclerosis and has been frequently detected in atheromatous plaques of the coronary arteries. Nevertheless, its distribution is not correlated to the severity or extent of the disease, but it would support the hypothesis that the organism may be an active factor in the pathogenesis of atherosclerosis. A group of patients with stable angina were examined as to whether or not the positivity of antibodies against Chlamydia pneumoniae modified cellular populations as mechanisms responsible for the alterations of inflammatory response. We concluded that the presence of IgG anti-C. pneumoniae antibodies do not participate in the activation of inflammatory mechanisms that may intervene in the genesis of atherosclerosis in patients with stable angina.
    Materias (normalizadas)
    Cardiovascular, Aparato, Efectos de los medicamentos sobre el
    Atherosclerosis
    Neumonia
    ISSN
    0167-5273
    Revisión por pares
    SI
    Idioma
    eng
    URI
    http://uvadoc.uva.es/handle/10324/5836
    Derechos
    openAccess
    Collections
    • DEP52 - Artículos de revista [181]
    Show full item record
    Files in this item
    Nombre:
    CASTRILLON 10[1].pdf
    Tamaño:
    38.27Kb
    Formato:
    Adobe PDF
    Descripción:
    PD-83
    Thumbnail
    FilesOpen
    Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcept where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10